Bronchitol — Medical Mutual
Cystic Fibrosis
Initial criteria
- Patient is age ≥ 18 years; AND
- Patient has tried hypertonic saline; AND
- Patient has passed the Bronchitol Tolerance Test; AND
- Patient will pre-medicate with a short-acting bronchodilator; AND
- Medication is prescribed by or in consultation with a pulmonologist or a physician who specializes in the treatment of cystic fibrosis; AND
- Medication is used as add-on maintenance therapy to improve pulmonary function
Reauthorization criteria
- Patient is age ≥ 18 years; AND
- Patient has tried hypertonic saline; AND
- Patient has passed the Bronchitol Tolerance Test; AND
- Patient will pre-medicate with a short-acting bronchodilator; AND
- Medication is prescribed by or in consultation with a pulmonologist or a physician who specializes in the treatment of cystic fibrosis; AND
- Medication is used as add-on maintenance therapy to improve pulmonary function; AND
- Patient has experienced an adequate response to therapy, as evidenced by improvement in FEV1 and/or other lung function tests per the prescribing physician
Approval duration
365 days